Ethyl 4-methyl-2-(pentylamino)-1,3-thiazole-5-carboxylate, 97%, 250mg

3,5-Di-tert-butyl-1,2-benzoquinone>98.0%(GC)25g

3-Heptenoic Acid>90.0%(GC)25mL

TERT-BUTYL 5-HYDROXY-HEXAHYDROCYCLOPENTA[C]PYRROLE-2(1H)-CARBOXYLATE, 97.0%, 25g

4-((4-fluorophenyl)sulfonyl)butanoyl chloride, 95.0%, 500mg

PF-2825, 98%, 100mg

tert-Butyl 2-(4-bromo-1H-pyrazol-1-yl)acetate, 97.0%, 1g

(3,5-Bis(methoxycarbonyl)phenyl)boronic acid, 95.0%, 25g

4-(1,3-benzodioxol-5-yl)-2-hydrazinopyrimidine, 95.0%, 25g

Carbon Nanotube Single-walled (>85%) below 3nm(Average diam.), over 5micro m(Average length)200mg

Columna HPLC NUCLEODUR® 300-5 C4 ec, 250 mm, 4,6 mm, 1 Pieza(s)

2,5-Difluoro-4-iodobenzonitrile, 5g

4-Benzo[1,3]dioxol-5-yl-thiazol-2-ylamine, 95.0%, 1g